Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Differential ACPA Binding to Nuclear Antigens Reveals a PAD-Independent Pathway and a Distinct Subset of Acetylation Cross-Reactive Autoantibodies in Rheumatoid Arthritis
Karolinska Univ Hosp, Karolinska Inst, Div Rheumatol, Ctr Mol Med,Dept Med, Stockholm, Sweden.
Karolinska Univ Hosp, Karolinska Inst, Div Rheumatol, Ctr Mol Med,Dept Med, Stockholm, Sweden;NIAMSD, Syst Autoimmun Branch, Intramural Res Program, NIH, Bethesda, MD 20892 USA.
Karolinska Univ Hosp, Karolinska Inst, Div Rheumatol, Ctr Mol Med,Dept Med, Stockholm, Sweden;Charite, Dept Med, Berlin, Germany.
Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.
Show others and affiliations
2019 (English)In: Frontiers in Immunology, ISSN 1664-3224, E-ISSN 1664-3224, Vol. 9, p. 1-22, article id 3033Article in journal (Refereed) Published
Abstract [en]

Rheumatoid arthritis (RA) associated anti-citrullinated protein autoantibodies (ACPA) target a wide range of modified proteins. Citrullination occurs during physiological processes such as apoptosis, yet little is known about the interaction of ACPA with nuclear antigens or apoptotic cells. Since uncleared apoptotic cells and neutrophil extracellular trap (NET) products have been postulated to be central sources of autoantigen and immunostimulation in autoimmune disease, we sought to characterize the anti-nuclear and anti-neutrophil reactivities of ACFA. Serology showed that a subset of anti-CCP2 seropositive RA patients had high reactivity to full-length citrullinated histones. In contrast, seronegative RA patients displayed elevated IgG reactivity to native histone compared to controls, but no citrulline-specific reactivity. Screening of 10 single B-cell derived monoclonal AGFA from RA patients revealed that four ACPA exhibited strong binding to apoptotic cells and three of these had anti-nuclear (ANA) autoantibody reactivity. Modified histones were confirmed to be the primary targets of this anti-nuclear ACPA subset following immunoprecipitation from apoptotic cell lysates. Monoclonal ACPA were also screened for reactivities against stimulated murine and human neutrophils, and all the nuclear-reactive monoclonal ACPA bound to NETs. Intriguingly, one ACPA mAb displayed a contrasting cytoplasmic perinuclear neutrophil binding and may represent a different NET-reactive ACPA subset. Notably, studies of CRISPR-Cas9 PAD4 KO cells and cells from PAD KO mice showed that the cytoplasmic NET-binding was fully dependent on PAD4, whilst nuclear- and histone-mediated NEI reactivity was largely PAD-independent. Our further analysis revealed that the nuclear binding could be explained by consensus-motif driven ACPA cross-reactivity to acetylated histones. Specific acetylated histone peptides targeted by the monoclonal antibodies were identified and the anti-modified protein autoantibody (AMPA) profile of the ACPA was found to correlate with the functional activity of the antibodies. In conclusion, when investigating monoclonal ACPA, we could group ACPA into distinct subsets based on their nuclear binding-patterns and acetylation-mediated binding to apoptotic cells, neutrophils, and NETs. Differential anti-modified protein reactivities of RA-autoantibody subsets could have an important functional impact and provide insights in RA pathogenesis.

Place, publisher, year, edition, pages
2019. Vol. 9, p. 1-22, article id 3033
Keywords [en]
anti-citrullinated protein autoantibodies, acetylation, rheumatoid arthritis, anti-CCP, PAD4, apoptosis, neutrophil extracellular traps (NETs), ANA
National Category
Rheumatology and Autoimmunity
Identifiers
URN: urn:nbn:se:uu:diva-374429DOI: 10.3389/fimmu.2018.03033ISI: 000454910500001PubMedID: 30662440OAI: oai:DiVA.org:uu-374429DiVA, id: diva2:1283180
Funder
Swedish Research CouncilSwedish Rheumatism AssociationAvailable from: 2019-01-28 Created: 2019-01-28 Last updated: 2019-01-28Bibliographically approved

Open Access in DiVA

fulltext(4262 kB)69 downloads
File information
File name FULLTEXT01.pdfFile size 4262 kBChecksum SHA-512
4f2d926e0c28004792383d769c2c20e97f1013fbed71a56b33167257795d3f0ad9b03df10c76b2a9d10be7dbd68ac6bfc18e3a1780154de440c02e3f48af6bc4
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMed

Search in DiVA

By author/editor
Rönnelid, Johan
By organisation
Department of Immunology, Genetics and Pathology
In the same journal
Frontiers in Immunology
Rheumatology and Autoimmunity

Search outside of DiVA

GoogleGoogle Scholar
Total: 69 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 68 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf